Avenacy Provides Update on 2025 Strategic Priorities Ahead of 43rd Annual J.P. Morgan Healthcare Conference

Schaumburg, Ill., United States:    Launched 14 critical injectable medicines since Company inception in October 2023 and remains on track

READ MORE

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2 Present at 43rd Annual J.P. Morgan Healthcare Conference

San Mateo, Calif., United States:   BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to

READ MORE